Faltering mortality improvements at young-middle ages in high-income English-speaking countries
International Journal of Epidemiology · 2024
DOI: 10.1093/ije/dyae128 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Epidemiology, 2024. Verfasst von Sergey Timonin und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Demography, College of Arts and Social Sciences, The Australian National University, Canberra, ACT, Australia. Hauptthemen laut MEDLINE: Life Expectancy, Developed Countries, COVID-19, Mortality. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council.
Abstract (Originalsprache)
Background
Before the COVID-19 pandemic, stagnating life expectancy trends were reported in some high-income countries (HICs). Despite previous evidence from country-specific studies, there is a lack of comparative research that provides a broader perspective and challenges existing assumptions. This study aims to examine longevity trends and patterns in six English-speaking countries (Australia, Canada, Ireland, New Zealand, United Kingdom, United States) by combining period and cohort perspectives and to compare them with other HICs.
Methods
Using data from the Human Mortality and World Health Organization Mortality Databases, we estimated partial life expectancy, lifespan inequality and cohort survival differences for 1970–2021, as well as the contribution of causes of death to the gap in life expectancy between English-speaking countries and the average for other HICs in 2017–19.
Results
In the pre-pandemic period, the increase in life expectancy slowed in all English-speaking countries, except Ireland, mainly due to stagnating or rising mortality at young-middle ages. Relative to other HICs, those born in Anglophone countries since the 1970s experienced relative survival disadvantage, largely attributable to injuries (mainly suicides) and substance-related mortality (mainly poisonings). In contrast, older cohorts enjoyed advantages for females in Australia and Canada and for males in all English-speaking countries except the United States.
Conclusions
Although future gains in life expectancy in wealthy societies will increasingly depend on reducing mortality at older ages, adverse health trends at younger ages are a cause for concern. This emerging and avoidable threat to health equity in English-speaking countries should be the focus of further research and policy action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Demography, College of Arts and Social Sciences, The Australian National University, Canberra, ACT, Australia.
- Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
- National Centre for Epidemiology and Population Health, College of Health and Medicine, The Australian National University, Canberra, ACT, Australia.
- Nossal Institute for Global Health, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
ORCID-Profile: Sergey Timonin, David A Leon, Emily Banks, Tim Adair, Vladimir Canudas-Romo
Förderung
- Australian Research Council
Zitieren
APA
Timonin, S., Leon, D. A., Banks, E., Adair, T., & Canudas-Romo, V. (2024). Faltering mortality improvements at young-middle ages in high-income English-speaking countries. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyae128
Vancouver
Timonin S, Leon DA, Banks E, Adair T, Canudas-Romo V. Faltering mortality improvements at young-middle ages in high-income English-speaking countries. International Journal of Epidemiology. 2024. doi:10.1093/ije/dyae128
BibTeX
@article{Timonin2024,
author = {Timonin, Sergey and Leon, David A and Banks, Emily and Adair, Tim and Canudas-Romo, Vladimir},
title = {Faltering mortality improvements at young-middle ages in high-income English-speaking countries},
journal = {International Journal of Epidemiology},
year = {2024},
doi = {10.1093/ije/dyae128}
}
EUVIMED